Neonatal hemochromatosis: it's OK to say "NO" to antioxidant-chelator therapy

Liver Transpl. 2005 Nov;11(11):1323-5. doi: 10.1002/lt.20541.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Antioxidants / therapeutic use*
  • Cause of Death*
  • Chelating Agents / therapeutic use
  • Female
  • Hemochromatosis / diagnosis
  • Hemochromatosis / drug therapy*
  • Hemochromatosis / mortality
  • Humans
  • Infant, Newborn
  • Infant, Newborn, Diseases / diagnosis
  • Infant, Newborn, Diseases / drug therapy
  • Infant, Newborn, Diseases / mortality
  • Liver Failure / diagnosis
  • Liver Failure / mortality*
  • Male
  • Prognosis
  • Rare Diseases
  • Risk Assessment
  • Severity of Illness Index
  • Survival Rate
  • Unnecessary Procedures*

Substances

  • Antioxidants
  • Chelating Agents